ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,823.86
-0.11%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Solid Biosciences Inc (SLDB)

  7. Solid Biosciences Inc (SLDB) 뉴스

SLDB Solid Biosciences Inc

10.10
-0.13 (-1.27%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Solid Biosciences Inc SLDB 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.13 -1.27% 10.10 13:00:10
개장가 저가 고가 종가 전일 종가
10.33 10.02 10.70 10.10 10.23
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/05/202405:05GLOBESolid Biosciences Reports Inducement Grants Under Nasdaq..
04/04/202405:05GLOBESolid Biosciences Reports Inducement Grants Under Nasdaq..
01/04/202420:45GLOBESolid Biosciences Receives Rare Pediatric Disease..
27/03/202420:00GLOBESolid Biosciences to Participate at Cantor’s Virtual..
13/03/202420:44GLOBESolid Biosciences Provides Fourth Quarter and Full-Year 2023..
07/03/202421:00GLOBESolid Biosciences Announces Licensing Agreement with Armatus..
06/03/202422:00GLOBESolid Biosciences to Participate at Upcoming Investor..
17/02/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202401:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202401:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202401:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/02/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
31/01/202407:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/01/202406:09EDGAR2Form S-3 - Registration statement under Securities Act of..
16/01/202422:50DJNSolid Biosciences Gets Orphan Drug Designation for SGT-003
16/01/202422:00GLOBESolid Biosciences Granted FDA Orphan Drug Designation for..
13/01/202407:05EDGAR2Form SC 13D/A - General statement of acquisition of..
12/01/202407:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202406:31EDGAR2Form SC 13D/A - General statement of acquisition of..
08/01/202421:24EDGAR2Form 8-K - Current report
08/01/202421:09GLOBESolid Biosciences Announces $109 Million Private Placement
06/01/202409:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202422:00GLOBESolid Biosciences to Participate at 42nd Annual J.P. Morgan..
08/12/202300:49DJNSolid Biosciences Shares Jump After FDA Fast-Tracks SGT-0003
07/12/202322:00GLOBESolid Biosciences Receives FDA Fast Track Designation for..
06/12/202304:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202304:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202304:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202304:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202322:00GLOBESolid Biosciences to Participate at 35th Annual Piper..
15/11/202322:51IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
15/11/202321:59EDGAR2Form 8-K - Current report
15/11/202306:05GLOBESolid Biosciences Announces IND Clearance by FDA for..
09/11/202322:00GLOBESolid Biosciences to Participate at Jefferies London..
09/11/202306:17GLOBESolid Biosciences Provides Third Quarter Business Update and..
09/11/202306:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
21/10/202305:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/10/202305:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/10/202321:00GLOBESolid Biosciences Appoints Gabriel Brooks, M.D., as Chief..
20/09/202321:00GLOBESolid Biosciences to Participate at Upcoming Investor..
07/09/202305:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/09/202321:56GLOBESolid Biosciences to Participate at Upcoming Investor..
31/08/202321:00GLOBESolid Biosciences to Participate in Citi’s 18th Annual..
15/08/202305:17GLOBESolid Biosciences Provides Second Quarter Business Update..
15/08/202305:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/06/202321:00GLOBESolid Biosciences to Participate at the Jefferies Healthcare..
22/05/202321:00GLOBESolid Biosciences to Participate at the Barclays Gene..
16/05/202321:00GLOBESolid Biosciences to Present at the American Society of Gene..

최근 히스토리

NASDAQ
SLDB
Solid Biosciences
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유